When Does Validation Start? A New Webinar Hosted by Xtalks
/EINPresswire.com/ -- TORONTO, ON --(Marketwired - May 03, 2016) - In the process of drug development, when should companies start good manufacturing practices (GMP)/Validation activities? What level of these activities are recommended or required at the different stages of drug development?
During a live broadcast on Friday, May 20, 2016, industry expert Troy Fugate, Vice President of Compliance Insight Inc., will discuss what level of Validation is required at the different stages of the pharmaceutical product development life cycle. These stages include development, clinical phases, and commercialization.
The session is aimed at assisting with the development of a Validation Program and Validation Master Plan and includes a live Q&A with the audience.
For more information or to register for this complimentary event, visit: When Does Validation Start?
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2016/5/2/11G096186/Images/Compliance_new_logo-89669589463.jpg
Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com
Compliance Insight offers hands-on compliance, quality assurance, clinical and regulatory affairs guidance and consulting that is reliable, accurate, timely and supportive of the client's goals and compliant with US FDA Regulations.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
